Search PubMed⌕ Search

Biomedical subjects

T Sonobe

Publications and source records attributed to T Sonobe.

At least 73 records · Page 4Linked to original sources
PubMed1990

Micro-pressure sensor for continuous monitoring of a ventricular assist device.

We have been involved in the development of a clinical ventricular assist device (VAD) system. Here, we report our investigation of in vitro and in vivo stability and sensibility of pressure microsensors. The sensors were mounted in the in-flow and out-flow cannulae wall to measure the left atrial and aortic pressures during VAD pumping. The pressure sensitive surface of the piezoresistive effect absolute pressure sensor was coated with a thrombo-resistant polymer, as was the inner surface of the cannulae of the VAD. In the in vitro and chronic animal experiments which were of more than a month duration, reliable stability and sensitivity, without any thrombus formation on the blood contacting surface of the sensors, and high sensitivity were observed. After chronic experiments, the sensitivity of sensors was reevaluated in the mock circulatory system as compared to reference values. The relationship between the output of the micro-sensors and the reference value was linear and correlated well.

Animals↗
PubMed1989

[A case of extramedullary plasmacytoma of the spleen].

A case of extramedullary plasmacytoma of the spleen in a 39 years-old man was reported. The tumor occupied almost of the spleen and extended to the transverse colon. 67Ga scintigraphy and MRI, particularly T 2-weighted image were useful in diagnosis of the localization.

Adult↗
PubMed1984

Cell growth-inhibitory effects of derivatives of antitumor cyclic hexapeptide RA-V obtained from Rubiae radix (V).

Alkylehter and ester derivatives of the antitumor cyclic hexapeptide RA-V obtained from the roots of Rubia cordifolia (Rubiaceae) were synthesized and bioassayed for activity against cultured tumor cells. RA-V and its n-hexylether showed significant effects against human nasopharynx carcinoma (KB), P388 lymphocytic leukemia and MM2 mammary carcinoma cells. The activity values (log 1/IC50) of ether derivatives of RA-V gave an upward parabolic or bilinear relationship when plotted against log P (P: partition coefficient determined with the 1-octanol/water system) as the carbon number of the side chain at the phenol moiety of RA-V was increased, the optimum log P values being in the range from 3.5 to 4.9. The ester derivatives showed a similar relationship, the optimum log P values being 6.3-6.7, which is higher than that of the ether derivatives. The lethal effect of RA-V on KB cells was clearly different from that of mitomycin C, and RA-V was concluded to be a "time-dependent drug" like vinblastine.

Animals↗
PubMed1983

Correlation of microenvironmental drug concentration with inhibition of growth of microorganisms on surfaces.

Methodologies have been developed to study the concept of microenvironmental drug concentration (C*) near or around microorganisms. C* may be calculated from data on drug release from a depot site by using appropriate diffusion relationships. By following C* and correlating this with the minimum inhibitory concentration (CMIC), one could attempt to predict the effectiveness of an antiplaque agent. When C* is less than CMIC, growth would be expected to occur; when C* is higher than or equal to CMIC, growth would not be expected. Chlorhexidine diacetate was chosen for this study, which used a system involving microorganisms present on the surface of drug-treated hydroxyapatite pellets. CMIC, defined as the lowest concentration to inhibit bacterial growth, was determined independently and under conditions similar to those used in the C* experiments. Surface growth of adhering microorganisms (Streptococcus mutans SL1) was followed by scanning electron microscopy. The parameters used in the calculation of C* were determined independently. Diffusion coefficients of the drugs and the diffusion layer thickness were determined under conditions similar to those employed in the release rate studies. Surface growth was generally found to be inhibited whenever C* was significantly greater than CMIC, and growth occurred whenever C* was significantly smaller than CMIC. These findings demonstrate how C* may determine the action of a topically administered antimicrobial agent and how the various physical and chemical factors play roles in influencing this quantity.

Anti-Infective Agents, Local↗